Market Overview - The Hong Kong stock market opened lower on October 6, with the Hang Seng Index down 0.61% to 26,976.52 points, the Hang Seng China Enterprises Index down 0.85% to 9,576.22 points, and the Hang Seng Tech Index down 1.20% to 6,543.62 points [1] Sector Performance - The gold and precious metals, mining, industrial engineering, and insurance sectors showed strength, while the real estate, oil and gas, and public utilities sectors remained active. The information technology, food and beverage, and telecommunications sectors led the declines [2] Gold and Precious Metals - The gold and precious metals sector in Hong Kong performed strongly, with notable individual stock movements: China Silver Group rose over 18%, Hong Kong Silver Holdings over 15%, Shandong Gold over 5%, Zijin Mining International over 5%, and Tongguan Gold over 2% [3][4] - International gold prices reached a new historical high, surpassing $3,900 per ounce, driven by increased global risk aversion, expectations of interest rate cuts by the Federal Reserve, and continued demand from central banks [4] Zijin Mining International - Zijin Mining International, which focuses on overseas gold asset integration, has seen its stock price nearly double since its listing on September 30, with a cumulative increase of 99.19%. The company holds 856 tons of gold reserves, ranking ninth globally, and has a production capacity of 40.4 tons, ranking eleventh [4] Semiconductor Sector - Hua Hong Semiconductor saw its stock price rise over 6% on October 6, reaching a new historical high. The stock price increased by 99.54% over 21 trading days since September 5. Goldman Sachs raised its target price for Hua Hong Semiconductor to HKD 117 per share, citing opportunities in China's expanding AI ecosystem [7] - Reports indicate that the semiconductor sector is expected to benefit from the growing demand for AI-related technologies, with significant opportunities in PC, automotive, and other smart hardware markets [7] Dingdang Health - Dingdang Health's stock surged by 34% during the trading session, closing up 26.8% at HKD 1.23 per share. The company is expanding its innovative drug offerings, recently launching a new anti-tumor drug and collaborating with major pharmaceutical companies [8][10]